BioInvent International AB (publ) (LON:0H22)

LON:0H22 Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-409.65	-330.3	-42.5	-278.44	-76.33	-138.63
Depreciation & Amortization	18.98	16.76	14.72	14.61	12	11.61
Stock-Based Compensation	6.48	2.95	1.79	1.14	-0.04	0.38
Other Operating Activities	3.32	-20.95	-8.46	-0.18	0.55	0.37
Change in Accounts Receivable	2.35	2.35	-38.73	23.35	-5.94	-3.19
Change in Inventory	-0.34	-0.34	5.34	-12.77	1.3	-2.43
Change in Other Net Operating Assets	24.31	-12.16	26.62	6.44	5.84	6.46
Operating Cash Flow	-354.55	-341.69	-41.23	-245.84	-62.62	-125.43
Capital Expenditures	-11.94	-13.3	-12.38	-13.26	-6.7	-3.84
Investment in Securities	493.94	72.99	-616.47	-454.28	-	-
Investing Cash Flow	482.01	59.68	-628.85	-467.54	-6.7	-3.84
Long-Term Debt Repaid	-	-7.82	-6.36	-5.92	-5.82	-5.68
Net Debt Issued (Repaid)	-8.28	-7.82	-6.36	-5.92	-5.82	-5.68
Issuance of Common Stock	-	30.96	279.85	900.79	650.44	220.07
Financing Cash Flow	-8.28	23.14	273.49	894.87	644.62	214.39
Miscellaneous Cash Flow Adjustments	8.39	3.37	0.88	-	-	-
Net Cash Flow	127.57	-255.5	-395.71	181.49	575.3	85.12
Free Cash Flow	-366.49	-355	-53.6	-259.1	-69.32	-129.27
Free Cash Flow Margin	-948.57%	-496.77%	-16.44%	-1336.68%	-47.04%	-137.90%
Free Cash Flow Per Share	-5.57	-5.40	-0.87	-4.78	-2.41	-7.13
Cash Interest Paid	0.64	0.64	0.65	0.52	0.34	0.48
Cash Income Tax Paid	0.2	0.09	-	-	-	-
Levered Free Cash Flow	-246.27	-235.5	-34.03	-156.68	-40.05	-75.02
Unlevered Free Cash Flow	-245.87	-235.1	-33.63	-156.36	-39.84	-74.72
Change in Net Working Capital	-26.06	9.91	6.22	-15	-1.75	-2.75

Source: S&P Capital IQ. Standard template. Financial Sources.